Form 4 for CRM Salesforce
Accepted 2021-12-22 00:00:00 ET · period of report 2021-12-22 · accession 0001127602-21-031817 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2021-12-22 | 2021-12-22 | CRM | Patterson Gavin | Pres, Chief Revenue Off | S - Sale+OE | $252.14 | -57.4K | 63.8K | -47% | -$14.46M |
| DM | 2021-12-22 | 2021-12-22 | CRM | Patterson Gavin | Pres, Chief Revenue Off | M - OptEx | $175.34 | +57.4K | 67.9K | +544% | +$10.06M |
| DM | 2021-12-22 | 2021-12-22 | CRM | Patterson Gavin | Pres, Chief Revenue Off | M - OptEx | $0.00 | -57.4K | 54.0K | -51% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-12-22 | S | D | 15,558 | $251.14 | 48,198 | D | — | — | (F3) Weighted average price. These shares were sold in multiple transactions at prices ranging from $250.5100 to $251.5000 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. |
| 2 | Common | Common Stock | 2021-12-22 | S | D | 14,157 | $252.88 | 19,577 | D | — | — | (F5) Weighted average price. These shares were sold in multiple transactions at prices ranging from $252.5200 to $253.4800 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. |
| 3 | Common | Common Stock | 2021-12-22 | S | D | 9,033 | $253.73 | 10,544 | D | — | — | |
| 4 | Common | Common Stock | 2021-12-22 | S | D | 14,464 | $252.09 | 33,734 | D | — | — | (F4) Weighted average price. These shares were sold in multiple transactions at prices ranging from $251.5100 to $252.5000 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. |
| 5 | Common | Common Stock | 2021-12-22 | M | A | 32,416 | $191.65 | 42,960 | D | — | — | |
| 6 | Common | Common Stock | 2021-12-22 | M | A | 24,936 | $154.14 | 67,896 | D | — | — | |
| 7 | Common | Common Stock | 2021-12-22 | S | D | 4,140 | $250.09 | 63,756 | D | — | — | (F2) Weighted average price. These shares were sold in multiple transactions at prices ranging from $249.5100 to $250.5000 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. |
| 8 | Derivative | Non-qualified Stock Option (Right to Buy) | 2021-12-22 | M | D | 24,936 | $0.00 | 34,909 | D | $154.14 · 2021-04-22 to 2027-04-22 | 24,936 Common Stock | (F7) Option vests over four years at the rate of 25% on April 22, 2021, the first anniversary of the holder's date of grant, with the balance vesting in equal monthly installments over the remaining 36 months. |
| 9 | Derivative | Non-qualified Stock Option (Right to Buy) | 2021-12-22 | M | D | 32,416 | $0.00 | 54,026 | D | $191.65 · 2021-06-22 to 2027-06-22 | 32,416 Common Stock | (F6) Option vests over four years at the rate of 25% on June 22, 2021, the first anniversary of the holder's date of grant, with the balance vesting in equal monthly installments over the remaining 36 months. |